| Record ID | marc_records_scriblio_net/part26.dat:180607515:1371 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part26.dat:180607515:1371?format=raw |
LEADER: 01371nam 2200277 a 4500
001 97121432
003 DLC
005 19990716000000.0
008 970205s1996 dcua f000 0 eng c
010 $a 97121432
020 $a0160537959
035 $a(OCoLC)36324214
040 $aDGPO/DLC$cDGPO$dDLC
043 $an-us---
050 00 $aKF27$b.G6685 1995g
074 $a1016-A
074 $a1016-B (MF)
086 0 $aY 4.G 74/7:F 73/19
110 1 $aUnited States.$bCongress.$bHouse.$bCommittee on Government Reform and Oversight.$bSubcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.
245 14 $aThe need for FDA regulatory reform to protect the health and safety of Americans :$bhearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995.
260 $aWashington :$bU.S. G.P.O. :$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$c1996.
300 $aiii, 169 p. :$bill. ;$c23 cm.
500 $aDistributed to some depository libraries in microfiche.
500 $aShipping list no.: 97-0097-P.
610 10 $aUnited States.$bFood and Drug Administration$xManagement.
650 0 $aDrugs$xTesting$xGovernment policy$zUnited States.